Bioventus (BVS) Shares Outstanding (2021 - 2026)
Bioventus (BVS) Shares Outstanding (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 385.10 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 867.00 Mn |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 951.57 Mn |
| 10 | Bioventus | 822.02 Mn | 786.18 Mn | 90.77 Mn | 67.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 67.30 Mn |
| Dec 31, 2025 | 66.62 Mn |
| Sep 27, 2025 | 66.92 Mn |
| Jun 28, 2025 | 66.50 Mn |
| Mar 29, 2025 | 66.01 Mn |
| Dec 31, 2024 | 64.55 Mn |
| Sep 28, 2024 | 65.26 Mn |
| Jun 29, 2024 | 64.06 Mn |
| Mar 30, 2024 | 63.38 Mn |
| Dec 31, 2023 | 62.65 Mn |
| Sep 30, 2023 | 62.82 Mn |
| Jul 1, 2023 | 62.55 Mn |
| Apr 1, 2023 | 62.12 Mn |
| Dec 31, 2022 | 61.39 Mn |
| Oct 1, 2022 | 61.67 Mn |
| Jul 2, 2022 | 61.48 Mn |
| Apr 2, 2022 | 60.48 Mn |
| Dec 31, 2021 | 45.47 Mn |
| Oct 2, 2021 | 41.84 Mn |
| Jul 3, 2021 | 41.81 Mn |